Akèy › Metiyè › Molecular and Cellular Biologists › Redwood City, CA

Molecular and Cellular Biologists nan Redwood City, CA: Salè H-1B

95 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Redwood City, CA. Salè baz medyàn ofri $137,280; mwatye mitan $109,142–$156,000.

Demann (LCA)95

Salè medyan ofri$137,280

Mwatye salè yo$109,142–$156,000

10yèm–90yèm pousantaj$89,200–$170,000

Pa nivo salè

Nivo revni	Salè medyan
Nivo I (antre)	$87,598
Nivo II (kalifye)	$122,000
Nivo III (eksperyans)	$141,975
Nivo IV (plen kompetans)	$169,000

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

Anplwayè	LCA	Salè medyan
Altos Labs Inc.	19	$128,350
Revolution Medicines, Inc.	13	$140,000
Codexis, Inc.	7	$129,065
Guardant Health, Inc.	6	$137,280
Earli Inc.	5	$92,500
Tempus AI	5	$150,000
Retro Biosciences, Inc.	4	$160,000
Adicet Bio, Inc.	4	$119,704
Chan Zuckerberg Institute for Advanced Biological Imaging, LLC	3	$140,000
Eigen Therapeutics Inc.	3	$170,000
Genpharm International LLC	2	$121,928
QIAGEN Redwood City, Inc.	2	$146,788
Integrated Biosciences, Inc.	2	$140,000
Shanda Asset Management LLC	2	$152,500
Tempus Labs, Inc.	1	$140,000
Bristol-Myers Squibb Company	1	$121,928
Somnology, Inc.	1	—
Soft Parch LLC	1	$101,816
ThinkCyte Inc.	1	$77,000
Afasci, Inc.	1	$76,461
Biomea Fusionn Inc.	1	$100,000
Eli Lilly and Company	1	$190,000
Auris Health, Inc.	1	$205,300
Integrated Dna Technologies	1	$152,238
Gilead Sciences, Inc.	1	$112,258
Whiterabbit. AI, Inc.	1	$168,000
Seer, Inc.	1	$157,000
Achelois BioPharma, Inc.	1	$85,197
CZ Biohub SF, LLC	1	$120,000
Allman Institute for Personalized Medicine LLC	1	$112,549
Chan Zuckerberg Biohub, Inc.	1	$169,000
Overland Therapeutics (US) Inc.	1	$168,000

Tit travay

Pwonse H-1B nan Redwood City, CA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).